Works matching IS 15430790 AND DT 2017 AND VI 15 AND IP S2
Results: 8
Myeloproliferative Neoplasms: Current Mutational Landscape of Myeloproliferative Neoplasms.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 17
- Publication type:
- Article
Highlights in Myeloproliferative Neoplasms From the 2016 American Society of Hematology Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 21
- By:
- Publication type:
- Article
Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 15
- Publication type:
- Article
Clinical Outcomes With Ruxolitinib (RUX) in Patients With Myelofibrosis (MF) Stratified By Transfusion Status: A Pooled Analysis of the COMFORT-I and -II Trials.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 13
- Publication type:
- Article
Examining the Clinical Features and Underlying Cardiovascular Risk Among Patients With Polycythemia Vera in the REVEAL Study.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 12
- Publication type:
- Article
Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients With Myelofibrosis (MF) Enrolled in the COMFORT-I Study.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 10
- Publication type:
- Article
Final Results From PROUD-PV, A Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 8
- Publication type:
- Article
A Pooled Overall Survival (OS) Analysis of 5-Year Data From the COMFORT-I and COMFORT-II Trials of Ruxolitinib for the Treatment of Myelofibrosis (MF).
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. S2, p. 6
- Publication type:
- Article